Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,004 INR | -0.13% | +1.60% | +45.65% |
05-06 | Zydus Lifesciences Arm Acquires Eiger BioPharmaceuticals' Progeria Drug | MT |
04-29 | Zydus Lifesciences Limited Receives A Demand Order-In-Original for the Financial Year 2018-19 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.65% | 12.12B | |
+20.14% | 43.74B | |
+21.93% | 22.26B | |
+16.41% | 14.9B | |
+10.47% | 13.39B | |
-9.58% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.41% | 5.47B | |
+8.29% | 4.83B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences Gets US FDA's Final Approval for Generic Acne Cream